ReviewFrontiers in immunology2026

From monoclonals to bispecific T cell engagers: the evolving antibody-based therapy landscape in acute myeloid leukemia.

Milad Rasouli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.